# Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

> **NCT01790308** · PHASE4 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** CSII
- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT01790308
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790308, "Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01790308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*